Fundraising FoxGreen Sands Equity — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesIA Seed VenturesLongitude CapitalOrbiMed+19 more
Axyon AI provides artificial intelligence tools for investment managers to develop alpha-generating strategies and improve portfolio construction and risk management.
AI & Machine LearningFintechSaaSModena, IT
Co-investorsCDP Venture CapitalING VenturesMontage VenturesSIMEST
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.